Gene · 701
Papers3,969
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,969
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Destabilization of microrchidia family CW-type zinc finger 2 via the cyclin-dependent kinase 1-chaperone-mediated autophagy pathway promotes mitotic arrest and enhances cancer cellular sensitivity to microtubule-targeting agents. | Clin Transl Med | 2023 | 36967563 | PubTator, text mining | PubMed |
| Nucleoporin 107 is a prognostic biomarker in hepatocellular carcinoma associated with immune infiltration. | Cancer Med | 2023 | 36952458 | PubTator, text mining | PubMed |
| Relationship between the deep features of the full-scan pathological map of mucinous gastric carcinoma and related genes based on deep learning. | Heliyon | 2023 | 36942252 | PubTator, text mining | PubMed |
| Genomic, epigenomic, and transcriptomic signatures of prostate cancer between African American and European American patients. | Front Oncol | 2023 | 36937425 | PubTator, text mining | PubMed |
| The structural flexibility of MAD1 facilitates the assembly of the Mitotic Checkpoint Complex. | Nat Commun | 2023 | 36934097 | PubTator, text mining | PubMed |
| Identification of prognostic and therapeutic biomarkers in type 2 papillary renal cell carcinoma. | World J Surg Oncol | 2023 | 36927438 | PubTator, text mining | PubMed |
| Mining the potential therapeutic targets for COVID-19 infection in patients with severe burn injuries via bioinformatics analysis. | Int Wound J | 2023 | 36924127 | PubTator, text mining | PubMed |
| Exploration and verification of COVID-19-related hub genes in liver physiological and pathological regeneration. | Front Bioeng Biotechnol | 2023 | 36911196 | PubTator, text mining | PubMed |
| Identification and validation of a novel ubiquitination-related gene UBE2T in Ewing's sarcoma. | Front Oncol | 2023 | 36910645 | PubTator, text mining | PubMed |
| Separase and Roads to Disengage Sister Chromatids during Anaphase. | Int J Mol Sci | 2023 | 36902034 | PubTator, text mining | PubMed |
| Identification of Prognostic Biomarkers for Suppressing Tumorigenesis and Metastasis of Hepatocellular Carcinoma through Transcriptome Analysis. | Diagnostics (Basel) | 2023 | 36900109 | PubTator, text mining | PubMed |
| PP6 regulation of Aurora A-TPX2 limits NDC80 phosphorylation and mitotic spindle size. | J Cell Biol | 2023 | 36897279 | PubTator, text mining | PubMed |
| Rare germline variants in pancreatic cancer and multiple primary cancers: an autopsy study. | Eur J Cancer Prev | 2023 | 36896836 | PubTator, text mining | PubMed |
| Differentially expressed discriminative genes and significant meta-hub genes based key genes identification for hepatocellular carcinoma using statistical machine learning. | Sci Rep | 2023 | 36882493 | PubTator, text mining | PubMed |
| Comparative transcriptome analysis identified crucial genes and pathways affecting sperm motility in the reproductive tract of drakes with different libido. | Poult Sci | 2023 | 36881978 | PubTator, text mining | PubMed |
| EWSR1 prevents the induction of aneuploidy through direct regulation of Aurora B. | Front Cell Dev Biol | 2023 | 36875767 | PubTator, text mining | PubMed |
| The progress in our understanding of CIN in breast cancer research. | Front Oncol | 2023 | 36874134 | PubTator, text mining | PubMed |
| Benzimidazole and its derivatives as cancer therapeutics: The potential role from traditional to precision medicine. | Acta Pharm Sin B | 2023 | 36873180 | PubTator, text mining | PubMed |
| Identification of GNG7 as a novel biomarker and potential therapeutic target for gastric cancer via bioinformatic analysis and in vitro experiments. | Aging (Albany NY) | 2023 | 36863706 | PubTator, text mining | PubMed |
| Structural mechanism for inhibition of PP2A-B56α and oncogenicity by CIP2A. | Nat Commun | 2023 | 36854761 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/701/papers?page=23